Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
12.45
-2.05 (-14.14%)
At close: Nov 20, 2024, 4:00 PM
13.07
+0.62 (4.98%)
After-hours: Nov 20, 2024, 4:08 PM EST
Zenas BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 520 | - | - |
| Enterprise Value | 134 | - | - |
| Debt / Equity Ratio | 0.00 | 0.87 | 0.03 |
| Asset Turnover | - | 0.70 | - |
| Quick Ratio | - | 2.44 | 2.59 |
| Current Ratio | - | 2.57 | 2.64 |
| Return on Equity (ROE) | - | -102.89% | - |
| Return on Assets (ROA) | - | -23.77% | - |
| Return on Capital (ROIC) | -72.26% | -35.79% | - |
| Buyback Yield / Dilution | -103.13% | -2.62% | - |
| Total Shareholder Return | -103.13% | -2.62% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.